TREACE MEDICAL CONCEPTS, INC. (TMCI)
↓ Download CSV- Sector Manufacturing
- Incorporated FL
- Fiscal year ends Dec 31
In fiscal 2025, TREACE MEDICAL CONCEPTS, INC. reported revenue of $212.69M, up 1.6% from the prior year. The company ran a net loss, with a net margin of -27.7% and a gross margin of 79.8%. It held $190.58M in total assets against $103.25M in total liabilities.
Key ratios (FY2025)
79.8%
Gross margin
-25.5%
Operating margin
-27.7%
Net margin
-67.6%
Return on equity
+1.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $212.69M | $209.36M | $187.12M | $141.84M | $94.42M | $57.37M | $39.42M | — |
| Cost of Revenue | $42.94M | $41.09M | $35.18M | $25.53M | $16.89M | $12.47M | $7.63M | — |
| Gross Profit | $169.75M | $168.26M | $151.94M | $116.31M | $77.53M | $44.90M | $31.79M | — |
| Operating Income | -$54.15M | -$55.69M | -$51.43M | -$34.84M | -$16.51M | $855.0K | -$3.54M | — |
| Net Income | -$59.00M | -$55.74M | -$49.53M | -$42.81M | -$20.55M | -$3.67M | -$4.26M | — |
| EPS (Diluted) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 | $-0.12 | — | — |
| Total Assets | $190.58M | $217.09M | $251.91M | $159.02M | $140.82M | $41.81M | — | — |
| Total Liabilities | $103.25M | $104.20M | $113.97M | $98.50M | $47.75M | $41.03M | — | — |
| Shareholders' Equity | $87.33M | $112.89M | $137.94M | $60.53M | $93.07M | $776.0K | $3.16M | $5.95M |
| Cash & Equivalents | $10.71M | $11.35M | $12.98M | $19.47M | $105.83M | $18.08M | $12.14M | $1.28M |
| Operating Cash Flow | -$15.97M | -$37.17M | -$34.58M | -$30.65M | -$17.19M | -$4.49M | -$7.67M | — |
| Capital Expenditures | $13.52M | $11.59M | $11.46M | $14.84M | $2.71M | $1.07M | $1.21M | — |
| Shares Outstanding | 63.27M | 62.11M | 60.85M | 55.28M | 48.42M | 37.07M | — | — |